Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Enanta Pharmaceuticals (ENTA) stocks
Learn how to easily invest in Enanta Pharmaceuticals stocks.
Enanta Pharmaceuticals is a biotechnology business based in the US. Enanta Pharmaceuticals stocks (ENTA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $71.5 – an increase of 10.45% over the previous week. Enanta Pharmaceuticals employs 155 staff and has a trailing 12-month revenue of around $91.6 million.
How to buy stocks in Enanta Pharmaceuticals
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ENTA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Enanta Pharmaceuticals?
- Has coronavirus impacted Enanta Pharmaceuticals shares?
- Enanta Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Enanta Pharmaceuticals stock a buy or sell?
- Enanta Pharmaceuticals performance over time
- Enanta Pharmaceuticals's financials
- How volatile are Enanta Pharmaceuticals shares?
- Does Enanta Pharmaceuticals pay a dividend?
- Other common questions
Enanta Pharmaceuticals stock price (NASDAQ:ENTA)Use our graph to track the performance of ENTA stocks over time.
Enanta Pharmaceuticals shares at a glance
|Latest market close||$45.01|
|52-week range||$37.59 - $102.00|
|50-day moving average||$51.74|
|200-day moving average||$65.73|
|Wall St. target price||$66.63|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-5.52|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Enanta Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Enanta Pharmaceuticals price performance over time
|1 week (2022-06-21)||11.69%|
|1 month (2022-05-27)||14.04%|
|3 months (2022-03-24)||-33.58%|
|6 months (2021-12-28)||-39.99%|
|1 year (2021-06-28)||0.07%|
|2 years (2020-06-26)||-9.40%|
|3 years (2019-06-28)||84.38|
|5 years (2017-06-28)||21.48%|
Is Enanta Pharmaceuticals under- or over-valued?
Valuing Enanta Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Enanta Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Enanta Pharmaceuticals's EBITDA
Enanta Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.8 million.
The EBITDA is a measure of a Enanta Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Enanta Pharmaceuticals financials
|Revenue TTM||$91.6 million|
|Gross profit TTM||$97.1 million|
|Return on assets TTM||-18.84%|
|Return on equity TTM||-28.27%|
|Market capitalisation||$932.3 million|
TTM: trailing 12 months
Enanta Pharmaceuticals share dividends
We're not expecting Enanta Pharmaceuticals to pay a dividend over the next 12 months.
Enanta Pharmaceuticals share price volatility
Over the last 12 months, Enanta Pharmaceuticals's shares have ranged in value from as little as $37.59 up to $102. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Enanta Pharmaceuticals's is 0.6742. This would suggest that Enanta Pharmaceuticals's shares are less volatile than average (for this exchange).
Enanta Pharmaceuticals overview
Enanta Pharmaceuticals, Inc. , a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. .
Stocks similar to Enanta Pharmaceuticals
Enanta Pharmaceuticals in the news
Is Enanta Pharmaceuticals (NASDAQ:ENTA) Using Debt Sensibly?
Enanta Pharmaceuticals (ENTA) Stock Jumps 10.1%: Will It Continue to Soar?
Cases climb in Southeast Asia and Europe in latest week as BA.4 and BA.5 subvariants take hold
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.Read more…
Here are some investment ideas that could do well despite rising interest rates.Read more…
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
More guides on Finder
Find the best investment newsletters in Canada
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.
How to buy Onfolio Holdings (ONFO) stock in Canada when it goes public
Everything we know about the Onfolio Holdings IPO plus information on how to buy in.
How to buy Acadian Timber stock in Canada
Steps to owning and managing ADN stock, with 24-hour and historical pricing before you buy.
How to buy Mobilicom Limited (MOB) stock in Canada when it goes public
Everything we know about the Mobilicom Limited IPO plus information on how to buy in.
How to buy Consumer Staples Select Sector SPDR Fund stock in Canada
Steps to owning and managing XLP stock, with 24-hour and historical pricing before you buy.
How to buy Schwab U.S. REIT ETF stock in Canada
Steps to owning and managing SCHH stock, with 24-hour and historical pricing before you buy.
How to buy iShares US Consumer Staples ETF stock in Canada
Steps to owning and managing IYK stock, with 24-hour and historical pricing before you buy.
How to buy Vanguard Real Estate Index Fund ETF Shares stock in Canada
Steps to owning and managing VNQ stock, with 24-hour and historical pricing before you buy.
How to buy SPDR S&P Insurance ETF stock in Canada
Steps to owning and managing KIE stock, with 24-hour and historical pricing before you buy.
How to buy Financial Select Sector SPDR Fund stock in Canada
Steps to owning and managing XLF stock, with 24-hour and historical pricing before you buy.